With 1.32 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.93 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $7.905 whereas the lowest price it dropped to was $7.59. The 52-week range on AVAH shows that it touched its highest point at $7.83 and its lowest point at $3.67 during that stretch. It currently has a 1-year price target of $7.56. Beta for the stock currently stands at 2.04.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AVAH was up-trending over the past week, with a rise of 9.03%, but this was up by 95.27% over a month. Three-month performance surged to 48.11% while six-month performance rose 86.02%. The stock gained 71.77% in the past year, while it has gained 40.18% so far this year. A look at the trailing 12-month EPS for AVAH yields 0.08 with Next year EPS estimates of 0.47. For the next quarter, that number is 0.07. This implies an EPS growth rate of 600.00% for this year and 11.23% for next year. EPS is expected to grow by 100.72% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 32.73%.
Float and Shares Shorts:
At present, 208.26 million AVAH shares are outstanding with a float of 44.84 million shares on hand for trading. On 2025-08-15, short shares totaled 2.07 million, which was 99.00000000000001 higher than short shares on 1752537600. In addition to Mr. Rodney D. Windley as the firm’s Executive Chairman, Mr. Jeffrey S. Shaner serves as its CEO & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-28, AVAH reported revenue of $589553000.0 and operating income of $83434000.0. The EBITDA in the recently reported quarter was $90438000.0 and diluted EPS was $0.13.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AVAH since 3 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AVAH analysts setting a high price target of 9.0 and a low target of 6.0, the average target price over the next 12 months is 7.55556. Based on these targets, AVAH could surge 14.65% to reach the target high and fall by -23.57% to reach the target low. Reaching the average price target will result in a decline of -3.75% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.01206284 being high and -$0.011788 being low. For AVAH, this leads to a yearly average estimate of $0.011788. The surprise factor in the prior quarter was -$0. Based on analyst estimates, the high estimate for the next quarter is $0.09 and the low estimate is $0.05. The average estimate for the next quarter is thus $0.07.
